Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3515465
Title:
MÉTHODES DE TRAITEMENT D'UNE DERMATITE ATOPIQUE SÉVÈRE PAR ADMINISTRATION D'UN INHIBITEUR DES IL-4R
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
177771458
WO application number:
US2017052772
Type:
European patent granted for BE
Status:
Open
Publication number:
3515465
WO publication number:
WO2018057776
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
21/09/2017
Grant date:
07/02/2024
EP publication date:
31/07/2019
WO publication date:
29/03/2018
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
07/02/2024
EP B1 publication date:
07/02/2024
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
21/09/2037
Applicant
1
Name:
Regeneron Pharmaceuticals, Inc.
Legal Form:
From:
07/02/2024
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)
To:
2
Name:
Sanofi Biotechnology
Legal Form:
From:
24/07/2024
Address:
82 Avenue Raspail, 94250 Gentilly, France (FR)
To:
Agent
1
Name:
KORSTEN Marius
Legal Form:
From:
12/12/2024
Address:
New Babylon City Offices
Anna van Buerenplein 21A, 2595 DA DEN HAAG, Netherlands (NL)